VORINOSTAT

Vorinostat is an HDAC inhibitor used for cutaneous T‑cell lymphoma, altering gene expression and inducing apoptosis. Side effects include fatigue, diarrhea, thrombocytopenia, and hyperglycemia.

SKU: 8c156f057475 Category: Tags: ,

Product Description


Mechanism of Action

VORINOSTAT (ID 27832) exhibits a high‑dimensional biochemical interaction matrix spanning signalling‑axis disruption, catalytic‑domain modulation, mitochondrial‑network recalibration, ion‑flux redistribution, cytoskeletal‑architecture remodelling, membrane‑potential rebalancing and transcription‑factor pathway restructuring. Its molecular topology supports interaction with catalytic residues, allosteric regulators, transmembrane helices, nucleotide‑binding pockets, redox‑buffer modules and polymeric scaffolding complexes, enabling wide‑band influence across metabolic, structural, genomic and electrophysiological domains.

Mechanistically, VORINOSTAT may reshape phosphorylation maps across ERK/MAPK/JNK/p38 axes, alter PI3K–AKT survival‑bias, modulate G‑protein coupling geometry, redistribute Ca²⁺ microdomain waveforms, adjust IP₃/DAG signalling topology and recalibrate cAMP–PKA amplitude. Mitochondrial impacts include ETC‑complex rebalancing, ATP/ADP cycle modulation, ROS‑threshold displacement, mitochondrial membrane‑potential polarity shifts and cross‑organelle stress signalling.

High‑Precision Research Applications

  • Kinome‑scale interference & catalytic‑cascade modelling
  • High‑resolution docking & conformational‑flow prediction
  • UPR/ER‑stress & autophagy/mitophagy integration networks
  • Full multi‑omics reconstruction (RNA‑seq, proteomics, phosphoproteomics, metabolomics)
  • Cytoskeletal force‑mapping & polymer turnover dynamics
  • Cell‑fate modelling: apoptosis, necroptosis, ferroptosis, parthanatos
  • AI‑driven SAR/QSAR predictive simulation

Toxicodynamics & Cellular Hazard Spectrum

  • Excessive ROS accumulation & antioxidant‑buffer collapse
  • Mitochondrial fragmentation or ETC suppression
  • Hyper‑disruption of Na⁺/K⁺/Ca²⁺ ionic‑gradients
  • Cytoskeletal degradation & membrane‑integrity failure
  • Inflammatory master‑switch activation (NF‑κB/STAT/IRF)
  • Multi‑axis programmed‑cell‑death induction
  • Epigenetic drift across methylation & acetylation layers

For expert laboratory research only — not intended for biological use.

Datasheet


Molecular Formula

C14H20N2O3

Molecular Weight

264.32 g/mol

CAS Number

149647-78-9

Storage Condition

Store at 20-25 °C (68-77 °F), excursions permitted between 15-30 °C (59-86 °F).

Solubility

Slightly soluble in ethanol, isopropanol and acetone; freely soluble in dimethylsulfide; insoluble in methylene chloride

Purity

Purity information is available upon request (COA).

Synonym

Vorinostat; 149647-78-9; SAHA; suberoylanilide hydroxamic acid; N-hydroxy-N'-phenyloctanediamide

IUPAC/Chemical Name

N'-hydroxy-N-phenyloctanediamide

InChl Key

WAEXFXRVDQXREF-UHFFFAOYSA-N

InChl Code

InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)

References

https://pubchem.ncbi.nlm.nih.gov/compound/5311;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download